Calamos Advisors »

Ascendis Pharma A/s shares owned by Calamos Advisors

Quarter-by-quarter ownership of Ascendis Pharma A/s shares owned by Calamos Advisors from 13F filings

Historical chart of Calamos Advisors investment in Ascendis Pharma A/s

Tip: Access up to 7 years of quarterly data

All positions including Ascendis Pharma A/s held by Calamos Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ascendis Pharma A/s by Calamos Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $9.8M 8.5M 1.16
2023-12-31 $8.7M 8.5M 1.03
2023-09-30 $7.8M 8.5M 0.92
2023-06-30 $7.8M 8.5M 0.91

More positions owned by Calamos Advisors

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Palo Alto Networks Note 0.375% 6/0 (Principal)
Eli Lilly & Co. (LLY)
Pioneer Nat Res Note 0.250% 5/1 (Principal)
Visa Com Cl A (V)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Alphabet Cap Stk Cl C (GOOG)
Broadcom (AVGO)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
UnitedHealth (UNH)

View all positions for Calamos Advisors

Top funds holding Ascendis Pharma A/s

Wolverine Asset Management
Braidwell
Franklin Resources
Aviva
Readystate Asset Management
D. E. Shaw & Co
Point72 Asset Management
Zazove Associates
CSS
Jane Street
Calamos Advisors
Capstone Investment Advisors
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
SSI Investment Management
DAFNA Capital Management

View all funds holding Ascendis Pharma A/s